After the recent closure of the Bo Xilai trial, expectation was that China’s current leader Xi Jinping would lay down for a while. But the opposite is happening as he takes on both Zhou Yongkang and Jiang Jiemin, a former and a current polit-bureau member, tells analyst Arthur Kroeber, according to Bloomberg.Read More →

Doubts on whether China is still the place to be for foreign companies are on the rise in media reports, especially now GlaxoSmithKline is on the chop board. Economic analyst Arthur Kroeber believes those headlines are deceiving and he explains in ChinaFile that foreign firm are profitable and want to expand.Read More →

China-bashing occurs in the odd years, notes China analyst Arthur Kroeber in ChinaFile, because in the even years – election years – US politicians have to focus on problems American really care about. This week, in 2013, the US Senate scrutinized the Smithfield-Shuanghui pork deal, one of the more sillier problems in US-China relations, writes Kroeber.Read More →

China’s GDP has depended largely on huge investments in infrastructure, rather than consumption. Economic analyst Arthur Kroeber argues in IBNLive that this policy is not longer possible, although ending it might be a tough call as the political transition asks for stability. Read More →